Aging Brain Cohort Dedicated to Diversity Study TAU PET
Enrolling By Invitation
99 years and younger
All
Phase
2
160 participants needed
1 Location
Brief description of study
To collect Tau PET imaging in cognitively normal older African American (AA) adults in the ABCD2 study to determine relationship to clinical, cognitive, and other biomarker data. Findings from this study will likely provide insight into the mechanisms and distinctions of age-related cognitive decline and that of Alzheimer's disease. Eligible subjects will be enrolled in the ABCD2 (protocol 844047).
The Flortaucipir racer will be manufactured by the UPENN Cyclotron and delivered to Radiology the day of the visit.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Age-related cognitive decline, Alzheimer's disease
-
Age: - 99 Years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 844403
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
